Claudius U Meyer
Overview
Explore the profile of Claudius U Meyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Meyer C, Zepp F, Decker M, Lee M, Chang S, Ward J, et al.
Clin Vaccine Immunol
. 2007 Feb;
14(3):288-92.
PMID: 17267589
Cell-mediated immune (CMI) responses to an acellular pertussis vaccine administered to 49 subjects, a subset of participants in the National Institutes of Health-funded adult acellular pertussis vaccine efficacy trial, were...
22.
Faber J, Meyer C, Gemmer C, Russo A, Finn A, Murdoch C, et al.
Pediatr Infect Dis J
. 2006 Jan;
25(1):80-1.
PMID: 16395111
Toll-like receptor 4 (TLR4) is required for efficient recognition of bacterial infections. We investigated an association between 2 TLR4 mutations (Asp(299)Gly and Thr(399)Ile) and meningococcal disease in 197 patients and...
23.
Zhou X, Schmidtke P, Zepp F, Meyer C
Curr Drug Targets Immune Endocr Metabol Disord
. 2005 Dec;
5(4):465-75.
PMID: 16375698
More than forty cytokines have been extensively researched on the molecular structure, cell signaling and transduction pathway. With respect to cytokine-regulating therapy in immunological imbalance however, the reported results are...
24.
Krumbiegel D, Rohr J, Schmidtke P, Knuf M, Zepp F, Meyer C
Clin Dev Immunol
. 2005 Jul;
12(2):99-105.
PMID: 16050140
Specific functional properties of dendritic cells (DCs) have been suspected as being responsible for the impaired specific immune responses observed in human neonates. To analyze stimulatory requirements for the critical...
25.
Zhou X, Meyer C, Schmidtke P, Zepp F
Eur J Pharmacol
. 2002 Oct;
453(2-3):309-17.
PMID: 12398919
Therapeutic options for controlling autoimmune diseases are still very limited. Interleukin-10 has been reported to be a promising approach to therapeutic intervention. In the search for a drug which results...